NCT04086966View on ClinicalTrials.gov

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 20, 2020

Primary Completion Date

February 23, 2022

Study Completion Date

February 23, 2022

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

[68Ga]PSMA-PET/MRI or PET/CT

\[68Ga\]PSMA-PET/MRI or PET/CT

Trial Locations (1)

35249

University of Alabama at Birmingham Medical Center, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT04086966 - PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study | Biotech Hunter | Biotech Hunter